A study conducted by Dr. Steven R Gundry and his medical group showed that blood tests drawn from patients 2 to 10 weeks following the 2nd COVID shot found measurements of protein biomarkers show an almost doubling of patients’ risk of a new Acute Coronary Syndrome (ACS). The study included 586 patients who had previously had their biomarkers measured prior to taking any of the Covid mRNA jabs.
Gundry’s practice uses “the PLUS CardiacTest (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS).”
The blood tests showed an increase of the PULS score from an 11% 5 year ACS risk to a 25% 5 year ACS risk. The patients’ risk of an acute coronary syndrome more than doubled and Gundry says, that at the time of the study’s publication, those risks persisted for at least 2.5 months.
Gundy’study concluded that:
…the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.AHA Journals